EP2456427 - Hot-melt extruded controlled release dosage form [Right-click to bookmark this link] | |||
Former [2012/22] | HOT-MELT EXTRUDED CONTROLLED RELEASE DOSAGE FORM | ||
[2014/36] | Status | No opposition filed within time limit Status updated on 08.01.2016 Database last updated on 02.09.2024 | Most recent event Tooltip | 12.10.2018 | Lapse of the patent in a contracting state New state(s): AL | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states Grünenthal GmbH Zieglerstrasse 6 52078 Aachen / DE | [2015/10] |
Former [2012/22] | For all designated states Grünenthal GmbH Zieglerstrasse 6 52078 Aachen / DE | Inventor(s) | 01 /
BARNSCHEID, Lutz Kornblumenweg 30 41239 Mönchengladbach / DE | 02 /
GALIA, Eric Franz-Wallraff-Strasse 1 52078 Aachen / DE | [2012/22] | Representative(s) | Bülle, Jan, et al Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | [N/P] |
Former [2015/10] | Bülle, Jan, et al Kutzenberger Wolff & Partner Theodor-Heuss-Ring 23 50668 Köln / DE | ||
Former [2012/22] | Bülle, Jan, et al Kutzenberger & Wolff Patentanwaltssozietät Theodor-Heuss-Ring 23 50668 Köln / DE | Application number, filing date | 10741907.9 | 21.07.2010 | WO2010EP04459 | Priority number, date | EP20090009499 | 22.07.2009 Original published format: EP 09009499 | [2012/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011009602 | Date: | 27.01.2011 | Language: | EN | [2011/04] | Type: | A1 Application with search report | No.: | EP2456427 | Date: | 30.05.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.01.2011 takes the place of the publication of the European patent application. | [2012/22] | Type: | B1 Patent specification | No.: | EP2456427 | Date: | 04.03.2015 | Language: | EN | [2015/10] | Search report(s) | International search report - published on: | EP | 27.01.2011 | Classification | IPC: | A61K9/20, A61K31/137 | [2012/22] | CPC: |
A61K9/2072 (EP,KR,US);
A61K31/137 (EP,KR,US);
A61K9/2031 (EP,KR,US);
A61K9/2054 (EP,KR,US);
A61K9/2095 (EP,KR,US);
A61P25/04 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/22] | Extension states | BA | Not yet paid | ME | Not yet paid | RS | Not yet paid | Title | German: | Heißschmelzextrudierte retardierte pharmazeutische Darreichungsform | [2014/36] | English: | Hot-melt extruded controlled release dosage form | [2014/36] | French: | Formule de dosage pharmaceutique extrudée thermofusible à libération prolongée | [2014/36] |
Former [2012/22] | HEISSSCHMELZEXTRUDIERTE RETARD-DARREICHUNGSFORM | ||
Former [2012/22] | HOT-MELT EXTRUDED CONTROLLED RELEASE DOSAGE FORM | ||
Former [2012/22] | FORME GALÉNIQUE EXTRUDÉE À CHAUD À LIBÉRATION CONTRÔLÉE | Entry into regional phase | 22.02.2012 | National basic fee paid | 22.02.2012 | Designation fee(s) paid | 22.02.2012 | Examination fee paid | Examination procedure | 06.05.2011 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 22.02.2012 | Examination requested [2012/22] | 24.09.2014 | Communication of intention to grant the patent | 15.01.2015 | Fee for grant paid | 15.01.2015 | Fee for publishing/printing paid | 15.01.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.09.2014 | Opposition(s) | 07.12.2015 | No opposition filed within time limit [2016/06] | Fees paid | Renewal fee | 13.07.2012 | Renewal fee patent year 03 | 10.07.2013 | Renewal fee patent year 04 | 14.07.2014 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 04.03.2015 | BG | 04.03.2015 | CY | 04.03.2015 | CZ | 04.03.2015 | DK | 04.03.2015 | EE | 04.03.2015 | FI | 04.03.2015 | HR | 04.03.2015 | LT | 04.03.2015 | LV | 04.03.2015 | MC | 04.03.2015 | MK | 04.03.2015 | MT | 04.03.2015 | RO | 04.03.2015 | SE | 04.03.2015 | SI | 04.03.2015 | SK | 04.03.2015 | SM | 04.03.2015 | TR | 04.03.2015 | NO | 04.06.2015 | GR | 05.06.2015 | IS | 04.07.2015 | PT | 06.07.2015 | IE | 21.07.2015 | LU | 21.07.2015 | [2018/46] |
Former [2018/30] | BG | 04.03.2015 | |
CY | 04.03.2015 | ||
CZ | 04.03.2015 | ||
DK | 04.03.2015 | ||
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
MC | 04.03.2015 | ||
MK | 04.03.2015 | ||
MT | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SI | 04.03.2015 | ||
SK | 04.03.2015 | ||
SM | 04.03.2015 | ||
TR | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
IE | 21.07.2015 | ||
LU | 21.07.2015 | ||
Former [2017/38] | BG | 04.03.2015 | |
CY | 04.03.2015 | ||
CZ | 04.03.2015 | ||
DK | 04.03.2015 | ||
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
MC | 04.03.2015 | ||
MT | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SI | 04.03.2015 | ||
SK | 04.03.2015 | ||
SM | 04.03.2015 | ||
TR | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
IE | 21.07.2015 | ||
LU | 21.07.2015 | ||
Former [2017/21] | CZ | 04.03.2015 | |
DK | 04.03.2015 | ||
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
MC | 04.03.2015 | ||
MT | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SI | 04.03.2015 | ||
SK | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
IE | 21.07.2015 | ||
LU | 21.07.2015 | ||
Former [2016/33] | CZ | 04.03.2015 | |
DK | 04.03.2015 | ||
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
MC | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SI | 04.03.2015 | ||
SK | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
IE | 21.07.2015 | ||
LU | 21.07.2015 | ||
Former [2016/15] | CZ | 04.03.2015 | |
DK | 04.03.2015 | ||
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
MC | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SI | 04.03.2015 | ||
SK | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
LU | 21.07.2015 | ||
Former [2016/13] | CZ | 04.03.2015 | |
DK | 04.03.2015 | ||
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
MC | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SI | 04.03.2015 | ||
SK | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
Former [2016/12] | CZ | 04.03.2015 | |
DK | 04.03.2015 | ||
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SI | 04.03.2015 | ||
SK | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
Former [2016/07] | CZ | 04.03.2015 | |
DK | 04.03.2015 | ||
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SK | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
Former [2015/50] | CZ | 04.03.2015 | |
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SK | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
IS | 04.07.2015 | ||
PT | 06.07.2015 | ||
Former [2015/49] | CZ | 04.03.2015 | |
EE | 04.03.2015 | ||
FI | 04.03.2015 | ||
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
RO | 04.03.2015 | ||
SE | 04.03.2015 | ||
SK | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
PT | 06.07.2015 | ||
Former [2015/39] | FI | 04.03.2015 | |
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
LV | 04.03.2015 | ||
SE | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
Former [2015/37] | FI | 04.03.2015 | |
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
SE | 04.03.2015 | ||
NO | 04.06.2015 | ||
GR | 05.06.2015 | ||
Former [2015/36] | FI | 04.03.2015 | |
HR | 04.03.2015 | ||
LT | 04.03.2015 | ||
SE | 04.03.2015 | ||
NO | 04.06.2015 | ||
Former [2015/35] | LT | 04.03.2015 | |
NO | 04.06.2015 | Cited in | International search | [A]DE4229085 (BOEHRINGER MANNHEIM GMBH [DE]) [A] 1-14 * claims 1-22 ** figures 1,2 *; | [X]DE4446470 (BASF AG [DE]) [X] 1-14 * paragraph [0013] - paragraph [0048] * * claims 1-8 *; | [X]DE102005005446 (GRUENENTHAL GMBH [DE]) [X] 1-14 * paragraph [0020] - paragraph [0105] * * claims 1-14 * * figure 1 *; | [X]WO2007103286 (SPHERICS INC [US], et al) [X] 1-14 * claims 1-62 * | by applicant | US4940556 | US5198226 | US5427798 | US2003064099 | WO2004043967 | WO2005016313 | WO2005016314 | WO2005066183 | WO2005102286 | WO2006002883 | WO2006002884 | WO2006002886 | WO2006082097 | WO2006082099 | - NING WU ET AL., JOURNAL OF CONTROLLED RELEASE, (2005), vol. 102, pages 569 - 81 | - V.S. MANTHENA ET AL., AM J DRUG DELIV., (2004), vol. 2, no. 1, pages 43 - 57 | - MM CROWLEY ET AL., DRUG DEV IND PHARM, (2007), vol. 33, no. 9, pages 909 - 26 | - "Guidance for Industry - Bioavailability and Bioequivalence - Studies for Orally Administered Drug Products - General Considerations", FDA, BP, ANNOUNCED IN THE FEDERAL REGISTER, (20030319), vol. 68, no. 53 | - P.A. PROESCHEL ET AL., J DENT RES, (2002), vol. 81, no. 7, pages 464 - 468 |